Angioplasty, Transluminal, Percutaneous Coronary
Research News and Information

Monday, November 23, 2009

Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).

Nov 2009 OBJECTIVES: The purpose of this study was to determine the prognostic value of ST-segment resolution after primary percutaneous coronary intervention (pPCI) versus fibrinolysis. BACKGROUND: Resolution of the ST-segment has been used as a surrogate ... Read more...

Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning.

18 Oct 2009 OBJECTIVES: This study was designed to characterize both regional left ventricular (LV) systolic and diastolic function after percutaneous coronary intervention by using strain imaging (SI) derived from 2-dimensional speckle-tracking ... Read more...

Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.

18 Oct 2009 Determining the most appropriate revascularization strategy for patients presenting with unprotected left main coronary (UPLM) disease has been a topic of great recent interest. During this current decade, there have been multiple clinical trials ... Read more...

Latest indexed articles for 'Angioplasty, Transluminal, Percutaneous Coronary'

These are the very latest articles for this heading:

• Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2). Nov 2009
• Stuck in the wrong place. 30 Oct 2009
• Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning. 18 Oct 2009
• Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. 18 Oct 2009
• Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. 13 Oct 2009
• Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris. 13 Oct 2009
• Routine early angioplasty after fibrinolysis. 6 Oct 2009
• Routine early angioplasty after fibrinolysis. 6 Oct 2009
• Routine early angioplasty after fibrinolysis. 6 Oct 2009
• Routine early angioplasty after fibrinolysis. 6 Oct 2009
• Routine early angioplasty after fibrinolysis. 6 Oct 2009
• Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention? 29 Sep 2009
• Angiographic results of the cobalt chromium Vision and Mini-Vision stents. 29 Sep 2009
• Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies. 29 Sep 2009
• Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry. 29 Sep 2009
• Design and rationale of the TRI-stent adjudication study (TRIAS) program. 29 Sep 2009
• Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. 29 Sep 2009
• Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
• Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
• Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Angioplasty, Transluminal, Percutaneous Coronary'

Definition: Dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.

Descriptor UI: D015906

Alternative terms: Angioplasty, Transluminal, Percutaneous Coronary; Angioplasty, Balloon, Coronary; Percutaneous Transluminal Coronary Angioplasty; Transluminal Coronary Balloon Dilatation; Balloon Dilatation, Coronary Artery; Coronary Angioplasty, Transluminal Balloon; PTCA; Angioplasty, Coronary Balloon; Angioplasties, Coronary Balloon; Balloon Angioplasties, Coronary; Balloon Angioplasty, Coronary; Coronary Balloon Angioplasties; Coronary Balloon Angioplasty;

Allowable Qualifiers: adverse effects; classification; economics; education; history; instrumentation; legislation & jurisprudence; methods; mortality; nursing; psychology; rehabilitation; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E02.148.050.060.100; E02.148.102.060.100; E04.100.376.719.100; E04.100.814.050.060.100; E04.928.220.520.100;

History Note: 90

Technical Notes: coord IM with disease /ther (IM), not /surg; do not use /util except by MeSH definition; if laser, coord IM with ANGIOPLASTY, BALLOON, LASER-ASSISTED (IM); DF: note short X ref